SIRT2 has been reported to prevent α synuclein-mediated toxicity in PD by deacetylating lysine 6 and 10 of α-synuclein preventing its aggregation and toxicity (Outeiro et al., 2007; de Oliveira et al., 2017). Here, SIRT2 is linked to Parkinson disease.